Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $47.3M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cassava Sciences USD 58M 24M Jun/2026
Chugai Pharma JPY 11.23T 985.7B Nov/2026
Cipla INR 1.09T 96.42B Sep/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 564.53M 41.47M Nov/2026
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
J&J USD 653.61B 42.25B Sep/2026
Neurocrine Biosciences USD 14.46B 45M Nov/2026
Pacira USD 1.69B 695M Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
RedHill Biopharma USD 8M 3M Jun/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024